Literature DB >> 11483165

Osteonecrosis and highly active antiretroviral therapy during HIV infection: report of a series and literature review.

L Calza1, R Manfredi, A Mastroianni, F Chiodo.   

Abstract

Osteonecrosis has shown an increased incidence in HIV-infected patients during the last few years, and has been looked as a side effect of highly active antiretroviral therapy, possibly related to hyperlipidemia. Five cases of osteonecrosis were observed among over 1300 patients with HIV disease. According to our experience, novel antiretroviral regimens do not represent a constant risk factor for avascular necrosis of bone during HIV infection.

Entities:  

Mesh：

Year:  2001        PMID： 11483165     DOI： 10.1089/108729101750301933

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN： 1087-2914            Impact factor:   5.078


  4 in total

1.  Avascular necrosis in HIV.

Authors:  Puja Mehta; Mark Nelson; Alexander Brand; Fiona Boag
Journal:  Rheumatol Int       Date:  2011-09-22       Impact factor: 2.631

2.  Avascular necrosis and protease inhibitors.

Authors:  Ramani Reddy; Monika N Daftary; Robert Delapenha; Arjun Dutta; Jacquay Oliver; Winston Frederick
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

Review 3.  HIV disease and advanced age: an increasing therapeutic challenge.

Authors:  Roberto Manfredi
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 4.  Musculoskeletal disorders associated with HIV infection and AIDS. Part II: non-infectious musculoskeletal conditions.

Authors:  Jamshid Tehranzadeh; Ramon R Ter-Oganesyan; Lynne S Steinbach
Journal:  Skeletal Radiol       Date:  2004-05-04       Impact factor: 2.199
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.